[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594142":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":91,"collaborators":10,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":10,"eligibilityCriteria":100,"healthyVolunteers":96,"sex":101,"minAge":102,"maxAge":10,"enrollmentInfo":103,"targetDuration":106,"studyType":107,"phases":10,"briefSummary":108,"conditions":109,"keywords":10,"overallStatus":113,"whyStopped":10,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":123},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"experimental group",null,"780 patients for interview",[13],"Other: interview",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"interview","30 for Qualitative interview and 750 for quantitative survey",[9],[20],{"name":21,"affiliation":5,"role":22},"Gang Chen, PhD","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Gang Chen","CONTACT","086-027-83662681","tjchengang@hust.edu.cn",[30,48,63,78],{"facility":31,"status":10,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Ying Zhou","Hefei","Anhui","230001","China","CN",{"type":38,"coordinates":39},"Point",[40,41],117.28083,31.86389,{"lat":41,"lon":40},[44],{"name":45,"role":26,"phone":46,"phoneExt":10,"email":47},"Ying Zhou, PhD","13865901025","caddie1234@gmail.com",{"facility":49,"status":10,"city":50,"state":51,"zip":52,"country":35,"countryCode":36,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Shuzhong Yao","Guangzhou","Guangdong","510080",{"type":38,"coordinates":54},[55,56],113.25,23.11667,{"lat":56,"lon":55},[59],{"name":60,"role":26,"phone":61,"phoneExt":10,"email":62},"Shuzhong Yao, ph.D","086-020-87755766","yszlfy@163.com",{"facility":25,"status":10,"city":64,"state":65,"zip":66,"country":35,"countryCode":36,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Wuhan","Hubei","430030",{"type":38,"coordinates":68},[69,70],114.26667,30.58333,{"lat":70,"lon":69},[73,74,77],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":75,"role":26,"phone":27,"phoneExt":10,"email":76},"Yingjie Hu","huyj@hust.edu.cn",{"name":25,"role":22,"phone":10,"phoneExt":10,"email":10},{"facility":79,"status":10,"city":80,"state":10,"zip":66,"country":35,"countryCode":36,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Dongling Zou","Chongqing",{"type":38,"coordinates":82},[83,84],106.55771,29.56026,{"lat":84,"lon":83},[87],{"name":88,"role":26,"phone":89,"phoneExt":10,"email":90},"Dongling Zou, ph.D","086-023-65301682","cqzl_zdl@163.com",{"type":22,"investigatorFullName":92,"investigatorTitle":93,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Gang Chen (101199)","Prof","100594142","patient-journey-in-advanced-gynecologic-cancers-100594142",false,"NCT07015593","Patient Journey in Advanced Gynecologic Cancers","Patient Journey in Conventional Therapy for Primarily Treated Advanced Gynecologic Cancers in China","Inclusion Criteria:\n\n* Age 18 or older\n* Newly diagnosed stage III or IV CC or EC\n* Completed their initial conventional therapies which must include at least chemotherapy, radiotherapy or a combination between Dec. 2022 to Dec. 2024 and the therapies were within 6 months after diagnosis.\n* Told by their physician that their disease is stable.\n* Patients must have informed consent form (ICF) signed for the study.\n\nExclusion Criteria:\n\n* Previously treated with targeted biologic therapy anti-PD-1, anti-PD-L1, or anti PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor.\n* Previously participated in or participating in a clinical trial.\n* Patients who received another line of therapy after initial therapy.\n* Unable or unwilling to provide informed consent.\n* Not fluent in local language.\n* Indicates or exhibits hearing difficulties, which would make a conversation challenging.","FEMALE","18 Years",{"count":104,"type":105},780,"ESTIMATED","1 Day","OBSERVATIONAL","This is a mixed-methods survey study including a 2-phased sequential-explanatory design. This study is to understand the patient journey in conventional therapy for newly diagnosed stage III or IV CC or EC in China, including ①patients' treatment decision making factors and treatment experiences and ② patients' unmet needs during post-treatment surveillance.",[110,111,112],"Genital Neoplasms, Female","Uterine Cervical Neoplasms","Endometrial Carcinoma","NOT_YET_RECRUITING","2025-06-04",{"date":116,"type":117},"2025-06-11","ACTUAL",{"date":119,"type":105},"2025-07-01",{"date":121,"type":105},"2026-11-30",{"name":5,"class":6},4]